Preview

Experimental and Clinical Gastroenterology

Advanced search

Evaluation of the estimated population prevalence of Helicobacter pylori infection and the frequency of achieving eradication after treatment based on the results of the 13C-urease breath test in individuals who applied to the federal network of the INVITRO laboratory (2019-2020, n=42,843)

https://doi.org/10.31146/1682-8658-ecg-186-2-47-51

Abstract

Purpose of research. Assessment of the population prevalence of Helicobacter pylori infection and the effectiveness of eradication therapy by analyzing the results of the13C-urease breath test (13C-UBT) of surveyed patients who applied for the test to the nationwide network of medical offices of the INVITRO laboratory in 2019-2020. Materials and methods.13C-UBT was performed using13C-UREA TEST kits and IR spectrometer IRIS° - Doc, Kibion AB, Sweden. A brief questionnaire was used when applying to clarify the purpose of the request, prior medication or gastric surgery. The evaluation of the prevalence of helicobacteriosis among those who applied for screening, and the effectiveness of eradication among those who applied for therapy control, was carried out by comparison of the specified point of the examination and the results of the13C-UBT test, based on a selected information from the laboratory database for 2019-2020 years (n=42843). Statistical calculations of quantitative results of13C-UBT performed using Excel, MS programs. Results. Primary screening of H. pylori infection was the goal of the examination for 69% (n=26,127), and eradication control for 31% (n=16,716) of the surveyed persons. According to the results of13C-UBT, using the threshold of positive results of 4.5% and the gray zone of 3.0-4.5%, among the primary screening subjects, 39% had a positive result, 3% - doubtful, others negative. In the group of patients who applied for eradication control, 40% of the subjects completed the full course of treatment. Among those who completed the course of treatment, the infection according to the results of13C-UBT remained in 15%, and for the group as a whole in 17% of patients. Conclusions. Among patients who applied to a large network laboratory for initial examination, the detection rate of H. pylori infection was 39%, which probably reflects the approximate current level of prevalence of this infection in the Russian Federation. According to the results of testing for treatment control, the effectiveness of eradication therapy was 80-82%.

About the Authors

M. S. Abdulova
LLC Independent Laboratory INVITRO
Russian Federation


N. A. Igonina
LLC Independent Laboratory INVITRO
Russian Federation


I. G. Torshina
LLC Independent Laboratory INVITRO
Russian Federation


E. V. Chashchikhina
LLC Independent Laboratory INVITRO
Russian Federation


E. A. Kondrasheva
LLC Independent Laboratory INVITRO
Russian Federation


N. A. Gasilova
LLC Independent Laboratory INVITRO
Russian Federation


P. A. Lipilina
LLC Independent Laboratory INVITRO
Russian Federation


I. V. Nasonenko
LLC Independent Laboratory INVITRO
Russian Federation


A. V. Aksenova
LLC Independent Laboratory INVITRO
Russian Federation


I. I. Doludenko
LLC Independent Laboratory INVITRO
Russian Federation


References

1. P. Malfertheiner, F. Megraud, C.A. O’Morain et al. Management of Helicobacter pylori infection - the Maastricht V. Florence Consensus Report. Gut. 2017; 66(1):6-30.

2. Ivashkin V.T., Mayev I. V., Lapina T. L., et al. Diagnostics and treatment of Helicobacter pylori infection in adults: Clinical guidelines of the Russian gastroenterological association. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2018;28(1):55-70. (In Russ.) doi: 10.22416/1382-4376-2018-28-1-55-70@@ Ивашкин В. Т., Маев И. В., Лапина Т. Л. и соавт. Клинические рекомендации Российской гастроэнтерологической ассоциации по диагностике и лечению инфекции Helicobacter pylori у взрослых. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2018; 28(1):55-70.

3. James K. Y. Hooi, Wan Ying Lai, Wee Khoon Ng et al. Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis. Gastroenterology. 2017 Aug; 153(2):420-429.

4. Zakharova N. V., Simanenkov V. I., Bakulin I. G., et al. Prevalence of helicobacter pylori infection in gastroenterological patients in saint Petersburg. Farmateka. 2016; s5-16:33-39. (In Russ.)@@ Захарова Н.В., Симаненков В. И., Бакулин И. Г. и соавт. Распространенность хеликобактерной инфекции у пациентов гастроэнтерологического профиля в Санкт-Петербурге. Фарматека. 2016; s5-16:33-39.

5. Bakulina N.V., Simanenkov V. I., Bakulin I. G., Ilchishina T. A. Prevalence of helicobacter pylori infection among physicians. Experimental and Clinical Gastroenterology. 2017;(12):20-24. (In Russ.)@@ Бакулина Н. В., Симаненков В. И., Бакулин И. Г., Ильчишина Т. А. Распростаненность хеликобактерной инфекции среди врачей. Экспериментальная и клиническая гастроэнтерология. 2017; (12):20-24.

6. Tseng-Shing Chen, Full-Young Chang, Pang-Chi Chen et al. Simplified 13C-urea breath test with a new infrared spectrometer for diagnosis of Helicobacter pylori infection. J Gastroenterol Hepatol. 2003 Nov; 18(11):1237-43.

7. M Zamani, F Ebrahimtabar, V Zamani et al. Systematic review with meta-analysis: the worldwide prevalence of Helicobacter pylori infection. Alimentary Pharmacology and Therapeutics. 2018 Apr; 47(7):868-876.


Review

For citations:


Abdulova M.S., Igonina N.A., Torshina I.G., Chashchikhina E.V., Kondrasheva E.A., Gasilova N.A., Lipilina P.A., Nasonenko I.V., Aksenova A.V., Doludenko I.I. Evaluation of the estimated population prevalence of Helicobacter pylori infection and the frequency of achieving eradication after treatment based on the results of the 13C-urease breath test in individuals who applied to the federal network of the INVITRO laboratory (2019-2020, n=42,843). Experimental and Clinical Gastroenterology. 2021;(2):47-51. (In Russ.) https://doi.org/10.31146/1682-8658-ecg-186-2-47-51

Views: 463


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1682-8658 (Print)